innovation passport

News

MHRA grants Innovation Passports to three novel drugs

The MHRA has awarded Innovation Passports to three drugs that could offer a step forwards in treating lung cancer, Huntington's, and Alzheimer's.

News

MHRA gives Alnylam 'innovation passport' for hypertension dr...

The UK medicines regulator has awarded Alnylam's RNAi-based therapy zilebesiran for hypertension an 'innovation passport', a

News

MHRA grants bluebird 'innovation passport' for sickle cell t...

bluebird bio's sickle cell disease (CD) gene therapy LentiGlobin is the latest recipient of an 'innovation passport' introduced in the UK earlier this year to speed up NHS access to promisi

MHRA grants Innovation Passports to three novel drugs

MHRA gives Alnylam 'innovation passport' for hypertension dr...

MHRA grants bluebird 'innovation passport' for sickle cell t...

Closing the global evidence gap in oncology, with Flatiron H...

Securing your ROI: Turning post-acquisition integration into...

Editor's Picks